Institution profile

医療法人健爽会 ReO Clinic

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01E2510033 +7

Location

Prefecture
Osaka
Address
大阪市中央区南船場2丁目5番17号

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 再生医療細胞治療特定認定再生医療等委員会
  • ヴィヴィアン特定認定再生医療等委員会
  • NPO法人抜苦ねっと認定再生医療等委員会

Public score

76.2/ 100

A · Review level
25.0 / 30
B · Technologies
25.3 / 35
C · Coverage
17.9 / 25
D · Class I / II technologies
8.1 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 76.2
Public score →100

Registered technologies (8)

Stem cells (all sources) 6
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた変形性関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来幹細胞を用いた糖尿病の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
自己脂肪由来幹細胞を用いた毛髪組織の治療Stem cells (all sources)Adipose-derived stem cellsHairClass II
自己脂肪由来幹細胞を用いたEDの治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 6
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた変形性関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来幹細胞を用いた糖尿病の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
自己脂肪由来幹細胞を用いた毛髪組織の治療Stem cells (all sources)Adipose-derived stem cellsHairClass II
自己脂肪由来幹細胞を用いたEDの治療Stem cells (all sources)Adipose-derived stem cellsClass II
NK and immune cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
悪性腫瘍に対する自家樹状細胞ワクチン療法NK and immune cellsClass III
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)NK and immune cellsClass III
Joints and musculoskeletal 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた変形性関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Hair 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた毛髪組織の治療Stem cells (all sources)Adipose-derived stem cellsHairClass II
Skin 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II

Certified committee for regenerative medicine

  • 再生医療細胞治療特定認定再生医療等委員会
  • ヴィヴィアン特定認定再生医療等委員会
  • NPO法人抜苦ねっと認定再生医療等委員会

Public document number

  • 01E2510033
  • 01E2510034
  • 01E2601003
  • 01E2601004
  • 01E2601005
  • 01E2601006
  • 01E2602004
  • 01E2602007
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己脂肪由来幹細胞を用いた慢性疼痛の治療Class II再生医療細胞治療特定認定再生医療等委員会01E2510033
自己脂肪由来幹細胞を用いた変形性関節症の治療Class II再生医療細胞治療特定認定再生医療等委員会01E2510034
自己脂肪由来幹細胞を用いたEDの治療Class IIヴィヴィアン特定認定再生医療等委員会01E2601003
自己脂肪由来幹細胞を用いた糖尿病の治療Class IIヴィヴィアン特定認定再生医療等委員会01E2601004
自己脂肪由来幹細胞を用いた顔面萎縮症・皮膚再生治療Class II再生医療細胞治療特定認定再生医療等委員会01E2601005
自己脂肪由来幹細胞を用いた毛髪組織の治療Class II再生医療細胞治療特定認定再生医療等委員会01E2601006
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)Class IIINPO法人抜苦ねっと認定再生医療等委員会01E2602004
悪性腫瘍に対する自家樹状細胞ワクチン療法Class IIINPO法人抜苦ねっと認定再生医療等委員会01E2602007

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor